Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1216704-96-9

Post Buying Request

1216704-96-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1216704-96-9 Usage

Uses

A labelled CNS stimulant.

Check Digit Verification of cas no

The CAS Registry Mumber 1216704-96-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,6,7,0 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1216704-96:
(9*1)+(8*2)+(7*1)+(6*6)+(5*7)+(4*0)+(3*4)+(2*9)+(1*6)=139
139 % 10 = 9
So 1216704-96-9 is a valid CAS Registry Number.

1216704-96-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-methyl-7-(trideuteriomethoxy)-9H-pyrido[3,4-b]indole

1.2 Other means of identification

Product number -
Other names Banisterine-d3

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1216704-96-9 SDS

1216704-96-9Downstream Products

1216704-96-9Relevant articles and documents

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

-

Paragraph 0392, (2019/10/15)

Described herein are compounds having the following structure: formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof. Also disclosed are compositions containing the compounds, methods of inhibiting activity of DYRKl A in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1216704-96-9